These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 35810398

  • 1. Low carnitine palmitoyltransferase 1 activity is a risk factor for narcolepsy type 1 and other hypersomnia.
    Honda M, Shigematsu Y, Shimada M, Honda Y, Tokunaga K, Miyagawa T.
    Sleep; 2022 Oct 10; 45(10):. PubMed ID: 35810398
    [Abstract] [Full Text] [Related]

  • 2. Abnormally low serum acylcarnitine levels in narcolepsy patients.
    Miyagawa T, Miyadera H, Tanaka S, Kawashima M, Shimada M, Honda Y, Tokunaga K, Honda M.
    Sleep; 2011 Mar 01; 34(3):349-53A. PubMed ID: 21358852
    [Abstract] [Full Text] [Related]

  • 3. Peroxisomes contribute to the acylcarnitine production when the carnitine shuttle is deficient.
    Violante S, Ijlst L, Te Brinke H, Koster J, Tavares de Almeida I, Wanders RJ, Ventura FV, Houten SM.
    Biochim Biophys Acta; 2013 Sep 01; 1831(9):1467-74. PubMed ID: 23850792
    [Abstract] [Full Text] [Related]

  • 4. Carnitine palmitoyltransferase 2 and carnitine/acylcarnitine translocase are involved in the mitochondrial synthesis and export of acylcarnitines.
    Violante S, Ijlst L, Te Brinke H, Tavares de Almeida I, Wanders RJ, Ventura FV, Houten SM.
    FASEB J; 2013 May 01; 27(5):2039-44. PubMed ID: 23322164
    [Abstract] [Full Text] [Related]

  • 5. Novel mutations associated with carnitine-acylcarnitine translocase and carnitine palmitoyl transferase 2 deficiencies in Malaysia.
    Habib A, Azize NAA, Rahman SA, Yakob Y, Suberamaniam V, Nazri MIBA, Abdullah Sani H, Ch'ng GS, Yin LH, Olpin S, Lock-Hock N.
    Clin Biochem; 2021 Dec 01; 98():48-53. PubMed ID: 34626609
    [Abstract] [Full Text] [Related]

  • 6. Intracellular in vitro probe acylcarnitine assay for identifying deficiencies of carnitine transporter and carnitine palmitoyltransferase-1.
    Purevsuren J, Kobayashi H, Hasegawa Y, Yamada K, Takahashi T, Takayanagi M, Fukao T, Fukuda S, Yamaguchi S.
    Anal Bioanal Chem; 2013 Feb 01; 405(4):1345-51. PubMed ID: 23143007
    [Abstract] [Full Text] [Related]

  • 7. Carnitine/acylcarnitine translocase and carnitine palmitoyltransferase 2 form a complex in the inner mitochondrial membrane.
    Console L, Giangregorio N, Indiveri C, Tonazzi A.
    Mol Cell Biochem; 2014 Sep 01; 394(1-2):307-14. PubMed ID: 24898781
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Metabolic interactions between peroxisomes and mitochondria with a special focus on acylcarnitine metabolism.
    Houten SM, Wanders RJA, Ranea-Robles P.
    Biochim Biophys Acta Mol Basis Dis; 2020 May 01; 1866(5):165720. PubMed ID: 32057943
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Carnitine-acylcarnitine translocase deficiency, clinical, biochemical and genetic aspects.
    Rubio-Gozalbo ME, Bakker JA, Waterham HR, Wanders RJ.
    Mol Aspects Med; 2004 May 01; 25(5-6):521-32. PubMed ID: 15363639
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Loss of Muscle Carnitine Palmitoyltransferase 2 Prevents Diet-Induced Obesity and Insulin Resistance despite Long-Chain Acylcarnitine Accumulation.
    Pereyra AS, Rajan A, Ferreira CR, Ellis JM.
    Cell Rep; 2020 Nov 10; 33(6):108374. PubMed ID: 33176143
    [Abstract] [Full Text] [Related]

  • 14. Lipocalin-type prostaglandin D synthase levels increase in patients with narcolepsy and idiopathic hypersomnia.
    Wang P, Li Q, Dong X, An H, Li J, Zhao L, Yan H, Aritake K, Huang Z, Strohl KP, Urade Y, Zhang J, Han F.
    Sleep; 2021 Apr 09; 44(4):. PubMed ID: 33175978
    [Abstract] [Full Text] [Related]

  • 15. Carnitine palmitoyltransferase 2: New insights on the substrate specificity and implications for acylcarnitine profiling.
    Violante S, Ijlst L, van Lenthe H, de Almeida IT, Wanders RJ, Ventura FV.
    Biochim Biophys Acta; 2010 Sep 09; 1802(9):728-32. PubMed ID: 20538056
    [Abstract] [Full Text] [Related]

  • 16. Differential carnitine/acylcarnitine translocase expression defines distinct metabolic signatures in skeletal muscle cells.
    Peluso G, Petillo O, Margarucci S, Grippo P, Melone MA, Tuccillo F, Calvani M.
    J Cell Physiol; 2005 May 09; 203(2):439-46. PubMed ID: 15515015
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Elucidation of the mechanism by which (+)-acylcarnitines inhibit mitochondrial fatty acid transport.
    Baillet L, Mullur RS, Esser V, McGarry JD.
    J Biol Chem; 2000 Nov 24; 275(47):36766-8. PubMed ID: 10986294
    [Abstract] [Full Text] [Related]

  • 20. Three novel mutations in the carnitine-acylcarnitine translocase (CACT) gene in patients with CACT deficiency and in healthy individuals.
    Fukushima T, Kaneoka H, Yasuno T, Sasaguri Y, Tokuyasu T, Tokoro K, Fukao T, Saito T.
    J Hum Genet; 2013 Dec 24; 58(12):788-93. PubMed ID: 24088670
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.